This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Aeneas Gmbh & Co. Kg. Active years: 2020-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2023
Title: Patricia Jeremias: Innovator in Coeliac Disease Diagnosis
Introduction
Patricia Jeremias is a notable inventor based in Woellstein, Germany. She has made significant contributions to the field of medical diagnostics, particularly in relation to coeliac disease and gluten sensitivity. With a total of 2 patents, her work is paving the way for advancements in early diagnosis and therapy control.
Latest Patents
One of her latest patents is a method for presymptomatic diagnosis of coeliac disease and gluten sensitivity. This invention involves the use of an immunologically reactive microbial transglutaminase or its immunologically reactive parts or analogues, which are present in a complex with gliadin or its immunologically reactive parts or analogues. This complex is utilized for the diagnosis and therapy control of coeliac disease or sprue, as well as gluten sensitivity. Additionally, she has developed a kit for determining the diagnosis and therapy control of these conditions using the aforementioned complex.
Career Highlights
Patricia Jeremias is currently associated with Aeneas GmbH & Co. KG, where she continues to innovate and contribute to the field of medical diagnostics. Her work is characterized by a commitment to improving patient outcomes through advanced diagnostic methods.
Collaborations
Throughout her career, Patricia has collaborated with notable colleagues, including Torsten Matthias and Kai Prager. These partnerships have further enhanced her research and development efforts in the medical field.
Conclusion
Patricia Jeremias stands out as a pioneering inventor in the realm of coeliac disease diagnosis. Her innovative methods and dedication to improving healthcare are commendable and reflect her significant impact on the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile